Compounds > thalidomide
Page last updated: 2024-08-16

thalidomide and pp-33

thalidomide has been researched along with pp-33 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, A; Hashimoto, Y; Kato, F; Kato, M; Kobayashi, Y; Miyachi, H; Ogasawara, A; Uchimura, E; Watanabe, N1
Hashimoto, Y; Iguchi, T; Inatsuki, S; Kizaki, M; Kobayashi, H; Miyachi, H; Noguchi, T; Oda, S1
Hashimoto, Y; Katayama, R; Miyachi, H; Naito, M; Noguchi, T1
Fujimoto, H; Hashimoto, Y; Miyachi, H; Miyajima, A; Noguchi, T; Sano, H1
de-Blanco, EJ; Hu, Z; Lewis, A; Li, PK; Pandit, B; Shi, J1

Other Studies

5 other study(ies) available for thalidomide and pp-33

ArticleYear
Novel biological response modifiers: phthalimides with tumor necrosis factor-alpha production-regulating activity.
    Journal of medicinal chemistry, 1997, Aug-29, Volume: 40, Issue:18

    Topics: Cell Survival; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Immunologic Factors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Okadaic Acid; Optical Rotation; Phthalimides; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1997
Tubulin-polymerization inhibitors derived from thalidomide.
    Bioorganic & medicinal chemistry letters, 2005, Jan-17, Volume: 15, Issue:2

    Topics: Colchicine; Indoles; Isoindoles; Lactones; Macrolides; Nerve Tissue Proteins; Thalidomide; Time Factors; Tubulin; Tubulin Modulators

2005
Cell differentiation inducers derived from thalidomide.
    Bioorganic & medicinal chemistry letters, 2005, Jul-01, Volume: 15, Issue:13

    Topics: Antineoplastic Agents; Cell Differentiation; Drug Screening Assays, Antitumor; Flow Cytometry; HL-60 Cells; Humans; Indoles; Isoindoles; Leukemia; Lipopolysaccharide Receptors; Structure-Activity Relationship; Thalidomide

2005
Angiogenesis inhibitors derived from thalidomide.
    Bioorganic & medicinal chemistry letters, 2005, Dec-15, Volume: 15, Issue:24

    Topics: Angiogenesis Inhibitors; Endothelium, Vascular; Humans; Structure-Activity Relationship; Thalidomide; Umbilical Veins

2005
Inhibitors of NF-kappaB derived from thalidomide.
    Bioorganic & medicinal chemistry letters, 2007, Nov-01, Volume: 17, Issue:21

    Topics: HeLa Cells; Humans; NF-kappa B; Thalidomide

2007